Introduction
Reye's syndrome is a disorder of unknown etiology characterized by the development of a fatty liver and a rapidly progressive encephalopathy in children recovering from such viral infections as influenza and chicken pox [ 1, 2] . By morphological and biochemical criteria, the mitochondria of the liver are severely affected 13'41.
The plasma free fatty acids are increased in affected patients [ 5 , 61 and it is well known that the activated form of the long chain fatty acids in the liver, the coenzyme A (CoA) esters, exert inhibitory effects on mitochondrial function [ 7, 81. To explore the possibility of a deleterious role for such compounds in this disorder, the concentrations of the CoA esters were measured in liver samples at autopsy from Reye's and control subjects.
Materials and methods
Clinical. Samples of human liver were collected at autopsy and kept at -7OOC until analysis. Summaries of the pertinent clinical features of the subjects from whom samples were obtained are presented in Tables 1 and 2 . The diagnosis of Reye' liver function. All samples were collected within 8 h of death. Most were collected between 3 and 4 h after death. Thirteen Reye's and 11 control samples were analysed. The mean age for the Reye's patients was 7.0 years, and was 7-3 years for the control patients excluding the foetus. The interval between the diagnosis of Reye's syndrome and death was 4.4 days, with a range of 0.5-10 days. This study was approved by the Institutional Review Board. Liver samples were also obtained from male Sprague-Dawley rats between 100 and 120 g in weight and allowed free access to laboratory chow and water. Rats were killed by cervical dislocation, except where indicated below when intraperitoneal Nembutal wqs used for anaesthesia before clamping of the visceral attachments of the liver.
Luborufory. Liver specimens were cut from frozen liver samples, weighed, minced while semi-frozen and homogenized in 3.5 vol. of 8% (v/v) perchloric acid in 40% ethanol at 4OC. The method used to separate the long chain versus the short chain CoA esters was based on the insolubility of the latter in such solutions [9] . Corroboration was by the recovery of 92,99 and 98% of added i3H1acetyl CoA in the supernatant fraction in human control liver homogenates and the nearly 95% recovery of [14C]palmitoyl CoA in the precipitate. Liver samples weighed between 0.5 and 1.0 g. After centrifugation at 25 000 g for 10 min, the precipitate was washed successively with 2.5 vol. of 5% HClO,, 0.6% HC10, and water followed by centrifugation and recovery of the pellet. The pellets were kept frozen until further analysis.
For analysis of the acid insoluble CoA esters, 2 vol. of dithiothreitol (10 mmol/l) was added to the pellet and the pH was raised to 12 with KOH solution (1 mol/l), followed by incubation at 55OC for 10 min. The pH was promptly reduced to 5 with 5% HC10,-triethanolamine/HCl (0.5 mol/l) before centrifugation at 25 000 g for 10 min. The supernatant fraction was analysed for CoA by the method of Allred & Guy [lo], after neutralization by measuring the conversion of NAD into NADH through the sequential use of malate dehydrogenase, citrate synthase and phosphotransacetylase at 340 nm. The commercially obtained citrate synthase, phosphotransacetylase and malate dehydrogenase used in this method were purchased from BoehringerMannheim and were extensively dialysed with Tris (1 mol/l), pH 7.20, to rid them of contaminating CoA before use. Standard curves of absorbance readings were generated over a range of CoA concentrations from 1 to 128 pmol/l for determination of the concentrations of the unknowns. The method allowed the detection of 0.5 nmol of CoA/ml. Duplicate samples varied within experimental error.
For the acid soluble CoA assays, liver was homogenized in 2 vol. of Tris buffer (1 mol/l), pH 7.2, at 4OC. One-half volume of 16% HClO, was then added and the preparation was spun at 25 000 g for 10 min. An aliquot of the supernatant fraction was made alkaline (to pH 12) with KOH solution (1 mol/l), followed by incubation at 5OoC for 35 min. The pH was promptly reduced to 5. The CoA content was thendetermined in both the alkaline-hydrolysed and neutralized sample and the untreated, unhydrolysed sample by the method of Allred Protein was determined by the method of Lowry with bovine serum albumin as a standard. Because of interference with this method by Tris, protein concentration was determined from a separate sample of liver, which was homogenized in water [ 1 11.
Results
Autopsied liver from Reye's syndrome and control subjects contained 1.06 f SEM 0-33 and 0.88 f 0.21 nmol of acid insoluble CoA compounds/g wet weight respectively. Variation was present in both groups and the mean values were not significantly different (Table 3) .
Supernatant fractions of liver homogenates acidified with 0.5 vol. of 16% HC10, contained large amounts of free CoA. This free CoA was readily destroyed with alkali at pH 12. Within a 4 min period at 5OoC, all of the free CoA is destroyed, as reflected by the failure to convert NAD into NADH in neutralized aliquots of such treated samples. Serial analysis of supernatant fractions of acidified rat liver homogenates exposed to alkali at 5OoC at 4 min intervals gave tracings with no detectable CoA after 4-8 min followed by the reappearance of CoA by 28-32 min, presumably as a result of CoA hydrolysed from ester linkages. After 60 min, no CoA is detectable, probably as a result of the complete destruction of the newly released CoA (Table 4) . Comparable findings were also noted in several human samples examined. Every Reye's sample had measurable quantities of acid soluble CoA compounds whereas two of six control samples had no detectable amounts. The mean (~S E M ) values found in both groups were 104.8 f 29.4 nmol/g wet weight for Reye's samples compared with 26.4 k 10.1 for control samples. The difference between the mean values was significant (P < 0.05) (see Table 3 ).
The Table 3 ).
Liver samples were also examined for sampling variability, which might contribute to these findings. In one control and one Reye's liver where the peripheral and proximal margins could be identified, identically-sized samples were removed from three sites, the proximal, middle and peripheral regions, for analysis as described (Table 3 ). The mean protein concentration in Reye's samples was 85-6 f 3.9 mg/g of tissue compared with 123 f 18.7 in control samples (P < 0.05).
To explore the possibility that differences were the result of post-mortem changes rather than due to premorbid conditions, the following studies were done: a Sprague-Dawley rat was anaesthetized with intraperitoneal Nembutal, after which the liver was-clamped at the vascular and ligamentous attachments with clamp A. Another clamp (B) was used to isolate the right lobe. A third clamp (C) was placed parallel to clamp B and the right lobe was removed by dividing the tissues between clamps B and C. The anaesthetized animal, with clamp A in place, was then placed in the refrigerator (4OC) before removal of the rest of the liver 4 h later. The liver was removed attached to clamp A. Both samples of the liver were frozen at -2OOC within minutes of removal from the animal. Each sample was processed and analysed for the acid insoluble CoA ester content as described above. The concentration was 0.23 1 nmol/mg of protein for the 0 h sample and 0.235 nmol/mg of protein for the 4 h sample. These findings indicate that no significant change in the concentration of the long chain fatty CoA esters occurs 4 h after death when the carcase is kept at 4°C.
Discussion
Fatty acyl CoA compounds are intermediates for both the catabolic as well as the biosynthetic processing of lipids from fatty acids. In the liver, the transport of the long chain fatty CoA compounds into the mitochondria for Poxidation requires carnitine as a carrier [12, 131. Carnitine levels have been found to be normal in the plasma in Reye's syndrome [141. Within the mitochondria, long chain fatty acyl CoA esters are potent inhibitors of the adenine nucleotide translocase and the tricarboxylic acid carrier systems [8, 12, . At low concentrations, long chain fatty CoA esters compete and efficiently inhibit ADP/ATP transport from both sides of the mitochondrial membrane 191. The interference with oxidative phosphorylation seen in starvation, diabetes and hibernation, which correlate with changes in high energy phosphate metabolism, is believed to be due to the effects of the accumulated long chain fatty CoA esters in the mitochondria [201. We had expected the possibility of an accumulation of the long chain fatty CoA esters, as reflected by increase in the acid insoluble CoA compounds in Reye's liver samples, which could be incriminated as the toxin responsible for the morphological and biochemical abnormalities of the mitochondria which are so prominent in this disorder. Instead, no significant difference in the total content of these compounds was found between Reye's and control samples.
On the other hand, a striking accumulation of the acid soluble CoA esters was found in Reye's samples. This class of esters includes the short chain fatty CoA compounds. On a molar basis, these esters are present at concentrations nearly fourfold those in control samples. In normal liver, &oxidation in the mitochondria is complete with the C, fragment entering the citric acid cycle for the even-carbon numbered fatty acids and the C, fragment entering the propionic acid pathway for the odd-carbon numbered fatty acids [211. The accumulation of the acid soluble CoA compounds, which include the short chain fatty CoA esters in the liver, is indicative of a block in the further oxidation of the long chain fatty acids in the mitochondria. These findings could account for the presence of a relative increase in the proportions of the medium to short chain fatty acids observed in the plasmas of many Reye's patients [ 5 , 6, 221. Increases in the concentrations of short chain fatty CoA compounds in the liver presumably occur in such genetically determined disorders as propionic acidaemia and methylmalonic acidaemia [23, 241. Reports of quantitative measurements of the CoA esters of the compounds involved have not yet come to our attention, but the CoA esters are believed to be responsible for the toxic effects of these metabolic conditions for the following reasons: the free acid in methylmalonic acidaemia was without clinical effects when administered to animals, and the administration of valine, a precursor of methylmalonic acid, to a vitamin B,,-deficient pig resulted in toxicity (vitamin B,, is a cofactor for the enzyme involved in methylmalonic acidaemia) 125, 261. Interestingly, evidence of mitochondrial dysfunction as reflected by interference with urea synthesis is a feature common to Reye's syndrome as well as to patients with propionic acidaemia and methylmalonic acidaemia [23,241.
Fatty acyl CoA compounds of long carbon chain lengths exert negative effects on the catalytic rates of a number of enzymes 127, 281. Detergent-like physical properties have been demonstrated for these compounds [281 and critical concentrations for micelle formation appear to occur within the concentration ranges which inhibit several of these enzymes [281. Several groups have, however, shown that the effects of fatty acyl CoA on enzymes may also be specific [27, 291. It is possible that these compounds found in Reye's samples may not be detrimental to the catalytic activities of enzymes by detergent-like mechanisms since the CoA esters of fatty acids of shorter chain lengths than ten carbon atoms are less deleterious. However, specific effects of such esters may still occur. Work is currently in progress to identify the chain lengths of these compounds. It also remains to be shown whether the accumulated short chain fatty CoA esters are limited to the mitochondria or are also present outside the mitochondria. Lazarow & de Duve [301 demonstrated the capability of rat liver peroxisomes to oxidize long chain fatty CoA esters by /3-oxidation. Unlike the mitochondrial system peroxisomal Poxidation is not coupled to phosphorylation. Like the mitochondrial system, acetyl CoA is generated through successive steps by dehydration, hydration, dehydrogenation and thiolytic cleavage [ 301. Whereas mitochondrial P-oxidation is normally complete, peroxisomal Poxidation is not. Only five acetyl CoA equivalents were obtained per equivalent of palmitoyl-CoA by the peroxisoma1 system. Furthermore, the isolated peroxisomes failed to oxidize the CoA esters of short chain fatty acids [311. Although the relative rate of the peroxisomal oxidation of fatty acids was found to proceed at only 10% of the mitochondria] rate [321, this system may be important in Reye's syndrome because of the significant increase in the numbers of these microbodies observed in liver biopsies [33, 341. It may thus be important to examine the subcellular distribution of these CoA esters of the fatty acids in the livers of affected subjects.
In conclusion, our findings indicate that an accumulation of the acid soluble CoA esters, probably largely due to medium and short chain fatty acyl CoA compounds, occurs in the liver of Reye's syndrome patients. This finding implicates a block in the P-oxidation of the fatty acids. It might be expected that the shorter chain fatty acids would be found in the plasma compartment since their transport out of the mitochondria does not require the carnitine carrier [35] . The possibility exists that the peroxisomes, which are increased in number in Reye's syndrome livers, may also play a role in the accumulation of these esters. The impact of these accumulations on enzymes and membranes could contribute to the pathophysiology of this disease.
